Jing Han
Compliance Officer at ALPHAMAB ONCOLOGY
Profile
Jing Han is currently the Chief Commercial Officer at Alphamab Oncology since 2021.
Prior to this, he worked as the Senior Vice President at Genor Biopharma Co., Ltd.
and as the Deputy GM & General Manager-Marketing Department at Shanghai Junshi Biosciences Co., Ltd.
from 2018 to 2020.
Mr. Han holds a Master's in Business Administration from China Europe International Business School and an undergraduate degree from Shanghai Jiao Tong University School of Medicine.
Jing Han active positions
Companies | Position | Start |
---|---|---|
ALPHAMAB ONCOLOGY | Compliance Officer | 2021-11-01 |
Former positions of Jing Han
Companies | Position | End |
---|---|---|
SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Sales & Marketing | 2020-08-14 |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Training of Jing Han
China Europe International Business School | Masters Business Admin |
Shanghai Jiao Tong University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
ALPHAMAB ONCOLOGY | Health Technology |
Private companies | 1 |
---|---|
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Jing Han